Supply Chain
New research from Advisory Board, conducted in partnership with Staples Business, reveals how 102 health system supply chain and executive…
Allergan Sales — a subsidiary of drugmaker Allergan — will acquire the privately-owned devicemaker Keller Medical for an undisclosed amount.
Recent clinical data on experimental cancer treatments points to strong future product sales, according to an emailed report from Moody's Investors Service.
The Food and Drug Administration on Wednesday approved Baxter International's clindamycin injection in saline.
Capital District Physicians' Health Plan in Albany, N.Y., is stepping up its fight against high drug prices with a new tactic — recruiting across enemy lines, reports The New York Times.
HSHS Medical Group, the physician organization of Springfield, Ill.-based Hospital Sisters Health System, will provide diabetes patients the MiniMed 670G insulin pump.
The Food and Drug Administration on Monday granted market clearance to Claret Medical's Sentinel Cerebral Protection System.
Republican Nevada Governor Brian Sandoval on June 2 vetoed a bill seeking to lower the price of diabetes treatments, reports Las Vegas Review Journal.
The Food and Drug Administration approved a new use for Edwards Lifesciences Corp.'s Sapien 3 artificial heart valve, reports Reuters.
Food and Drug Administration Commissioner Scott Gottlieb, MD, outlined his strategy to lower drug prices during a Monday interview with Bloomberg.
Lung Therapeutics, a pharmaceutical company establishing new treatments for niche drug indications in fibrosis, lung injuries and diseases, announced Tuesday that it raised $14.3 million in a Series B financing.